Administration, Intranasal

"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Delivery of medications through the nasal mucosa.

Descriptor ID	D000281
MeSH Number(s)	E02.319.267.120.655.500
Concept/Terms	Administration, Intranasal Administration, Intranasal Intranasal Drug Administration Drug Administration, Intranasal Intranasal Administration Administrations, Intranasal Intranasal Administrations Administration, Intranasal Drug Administrations, Intranasal Drug Drug Administrations, Intranasal Intranasal Drug Administrations Administration, Nasal Administrations, Nasal Nasal Administration Nasal Administrations

Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Topical [E02.319.267.120]
Administration, Mucosal [E02.319.267.120.655]
Administration, Intranasal [E02.319.267.120.655.500]

Below are MeSH descriptors whose meaning is related to "Administration, Intranasal".

Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.

Bar chart showing 61 publications over 25 distinct years, with a maximum of 6 publications in 1999 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1999	0	6	6
2001	0	4	4
2002	0	3	3
2003	0	1	1
2004	0	2	2
2006	0	6	6
2007	1	2	3
2008	0	4	4
2009	0	1	1
2010	1	0	1
2011	0	1	1
2012	0	2	2
2013	0	1	1
2014	0	2	2
2015	0	2	2
2016	0	1	1
2017	0	3	3
2018	0	3	3
2019	0	3	3
2021	0	2	2
2022	0	1	1
2023	0	2	2
2024	2	3	5
2025	0	1	1

Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.

Pan WY, Weng PW, Wu SH, Hsiao CH, Jheng PR, Nguyen HN, Tseng CL, Burnouf T, Rethi L, Nguyen HT, Huang WY, Wang TJ, Chuang AE. Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma. J Control Release. 2025 May 10; 381:113596.

View in: PubMed
Richardson S, Medhavi FNU, Tanner T, Lundy S, Omosun Y, Igietseme JU, Eko FO. Role of route of delivery on Chlamydia abortus vaccine-induced immune responses and genital tract immunity in mice. Microbes Infect. 2025 Mar-Apr; 27(3):105463.

View in: PubMed
Chuang AE, Chen YL, Chiu HJ, Nguyen HT, Liu CH. Nasal administration of polysaccharides-based nanocarrier combining hemoglobin and diferuloylmethane for managing diabetic kidney disease. Int J Biol Macromol. 2024 Dec; 282(Pt 1):136534.

View in: PubMed
Joseph J, Baby HM, Quintero JR, Kenney D, Mebratu YA, Bhatia E, Shah P, Swain K, Lee D, Kaur S, Li XL, Mwangi J, Snapper O, Nair R, Agus E, Ranganathan S, Kage J, Gao J, Luo JN, Yu A, Park D, Douam F, Tesfaigzi Y, Karp JM, Joshi N. Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory Infections. Adv Mater. 2024 11; 36(46):e2406348.

View in: PubMed
Sefat KMSR, Kumar M, Kehl S, Kulkarni R, Leekha A, Paniagua MM, Ackart DF, Jones N, Spencer C, Podell BK, Ouellet H, Varadarajan N. An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine. 2024 09 17; 42(22):125909.

View in: PubMed
Yu YS, Xu H, AboulFotouh K, Williams G, Suman J, Sahakijpijarn S, Cano C, Warnken ZN, Wu KC, Williams RO, Cui Z. Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system. Int J Pharm. 2024 Mar 25; 653:123892.

View in: PubMed
Yu J, Li J, Matei N, Wang W, Tang L, Pang J, Li X, Fang L, Tang J, Zhang JH, Yan M. Intranasal administration of recombinant prosaposin attenuates neuronal apoptosis through GPR37/PI3K/Akt/ASK1 pathway in MCAO rats. Exp Neurol. 2024 Mar; 373:114656.

View in: PubMed
Yu YS, AboulFotouh K, Xu H, Williams G, Suman J, Cano C, Warnken ZN, Wu KC, Williams RO, Cui Z. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders. Int J Pharm. 2023 Jun 10; 640:122990.

View in: PubMed
Yu S, Doycheva DM, Gamdzyk M, Gao Y, Guo Y, Travis ZD, Tang J, Chen WX, Zhang JH. BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model. Oxid Med Cell Longev. 2022; 2022:4054938.

View in: PubMed
Zuo Z, Zou Y, Li Q, Guo Y, Zhang T, Wu J, He C, Eko FO. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge. Sci Rep. 2021 05 17; 11(1):10389.

View in: PubMed

People

Explore

Similar Concepts

Top Journals